Neurocrine Biosciences, Inc. (NBIX)

Neurocrine Biosciences Market Cap

Neurocrine Biosciences has a market cap or net worth of $15.81 billion as of May 19, 2026. Its market cap has increased by 44.55% in one year.

• Market Cap: 15.81B
• Enterprise Value: 14.95B
• 1-Year Change: 44.55%
• Ranking: #699
• Category: Large-Cap
• Stock Price: $157.21

Market Cap Chart

Since December 1, 1998, Neurocrine Biosciences's market cap has increased from $124.10M to $15.81B, an increase of 12,637.68%. That is a compound annual growth rate of 19.29%.

Market Cap History

Date	Market Cap	% Change
May 18, 2026	15.81B	11.78%
Dec 31, 2025	14.14B	2.32%
Dec 31, 2024	13.82B	6.76%
Dec 29, 2023	12.95B	12.74%
Dec 30, 2022	11.48B	42.11%
Dec 31, 2021	8.08B	-9.78%
Dec 31, 2020	8.96B	-9.54%
Dec 31, 2019	9.90B	52.87%
Dec 31, 2018	6.48B	-5.69%
Dec 29, 2017	6.87B	104.24%
Dec 30, 2016	3.36B	-31.05%
Dec 31, 2015	4.88B	187.17%
Dec 31, 2014	1.70B	169.95%
Dec 31, 2013	629.00M	26.66%
Dec 31, 2012	496.60M	5.73%
Dec 30, 2011	469.70M	12.07%
Dec 31, 2010	419.10M	293.15%
Dec 31, 2009	106.60M	-13.68%
Dec 31, 2008	123.50M	-28.41%
Dec 31, 2007	172.50M	-56.31%
Dec 29, 2006	394.80M	-82.96%
Dec 30, 2005	2.32B	28.86%
Dec 31, 2004	1.80B	-6.54%
Dec 31, 2003	1.92B	37.67%
Dec 31, 2002	1.40B	3.88%

View and export this data all the way back to 1998. Sign Up Today.

Data Source: Nasdaq Data Link Last updated: May 18, 2026

Market cap data is provided by Nasdaq Data Link. The current market cap updates continuously throughout the trading day, while the historical market cap is updated daily after market close.

Update frequency:

Daily

Last checked:

May 18, 2026

Data Sources Report a data error

Related Stocks

Company	Market Cap
Teva Pharmaceutical Industries	39.93B
Haleon	39.37B
Zoetis	31.12B
United Therapeutics	24.13B
Viatris	19.19B
Regencell Bioscience Holdings	14.13B
Dr. Reddy's Laboratories	11.60B
Elanco Animal Health	9.92B